Getwell Oncology has established itself as one of the most trusted Oncology PCD Pharma Franchise Companies in India, dedicated exclusively to developing and manufacturing advanced oncology formulations. Established in 1985, the company has over three decades of expertise in producing high-quality cancer care medicines and sterile injectable formulations for domestic and international markets. Today, Getwell Oncology serves healthcare professionals and institutions across 25+ countries, reinforcing its global reputation for quality, innovation, and reliability.

The company specializes in manufacturing liquid injectables, lyophilized formulations, oral solid dosage forms, liposomal products, nanoparticle-based drug delivery systems, and supportive oncology medicines. Its portfolio includes more than 35 oncology products designed for the treatment of solid tumors, hematological malignancies, and palliative cancer care. Manufactured in technologically advanced facilities complying with US FDA and EU GMP standards, every product is developed through rigorous research, advanced formulation technologies, and stringent quality assurance protocols.

Getwell Oncology also offers comprehensive partnership opportunities through contract manufacturing, technology transfer, product development, packaging support, and regulatory assistance. Backed by an experienced R&D team, world-class infrastructure, and a commitment to scientific innovation, the company continues to strengthen its position as one of India's leading Oncology PCD Pharma Franchise Companies, delivering reliable cancer care solutions that improve patient outcomes worldwide.